UNMATCHED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES INDUSTRY

582
Active Clinical Trials
8
Commercial Products
450,000+
Shipments
150+
Countries
2022’s Data ManagementTransitionsWebinar

2022’s Data Management Transitions Webinar

Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?

  • How will capacity and connectivity challenges impact carrier services and packaging technology providers?
  • How can you guarantee the certainty of global coverage and data fidelity for your cell and gene therapy shipments?
WATCH NOW
Download our ISO 21973 White Paper

Download our ISO 21973 White Paper

A leap forward in standardizing the regenerative medicine supply chain

  • Ensuring full compliance at every step in the transportation process
  • Standardization at scale
  • Mitigating risk in a zero failure environment
LEARN MORE

Upcoming Events View All

JAN25

International Production and Processing Expo 2022

Date: January 25-27, 2022
Location: Atlanta, GA

JAN25

Advanced Therapies Week 2022

Date: January 25-28, 2022
Location: Miami, FL

The Latest From Our Blog View All

2022 Updates to the Harmonized System (HS) and Harmonized Tariff Schedule (HTS)

Update: President Biden signed Proclamation 10326 To Modify the Harmonized Tariff Schedule of the United States and for Other Purposes on December 23rd, 2021. Thus, Customs and Border Protection (CBP) has made January 27th, 2022 the effective date for all changes to the US tariff schedule.

Every five years the World Customs Organization (WCO) conducts a general review of the Harmonized Commodity Description and Coding System (Harmonized System or HS- refer to Appendix A). The WCO is an international body made up of representatives from 183 customs administrations around the world. These reviews are designed to keep the HS current with new technology, visibility into product streams and emerging global issues.

Cryoport Systems & CRYOPDP Synergies Provide Integrated and Flexible Temperature-Controlled Supply Chain Solutions for the Life Sciences

Biotech companies continue to innovate cutting-edge therapeutics, and the companies that support their efforts continue to strive for best practices as these new therapies advance and evolve. In the field of advanced therapy logistics, a risk-averse culture with a zero-failure tolerance mindset sits at the heart of innovative thinking and a dedication to always improving.

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

Exciting News! Cryoport, Inc., our parent company, has expanded its family of companies in continuing to support temperature controlled supply chain solutions for the life sciences industry. Learn More